J. T. Pepin*, H. Cardenas, K. P. Nephew, D. Matei

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


Ovarian cancer (OC) is characterized by complex epigenetic alterations, including aberrant DNA methylation, histone modifications, and nucleosome positioning. Advances in the sequencing technologies over the past decade have enabled deeper characterization of the chromatin landscape in cancer. Alterations of the epigenome have been implicated in tumor progression, development of chemotherapy resistance, persistence, and survival of cancer stem cells. As the machinery governing epigenetic changes is being deciphered, the OC epigenome will become an important new therapeutic cancer target.

Original languageEnglish (US)
Title of host publicationTranslational Advances in Gynecologic Cancers
PublisherElsevier Inc
Number of pages24
ISBN (Electronic)9780128037980
ISBN (Print)9780128037416
StatePublished - Feb 22 2017


  • DNA methylation
  • Epigenome
  • Histone modifications
  • Ovarian cancer

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Epigenetics'. Together they form a unique fingerprint.

Cite this